Several retrospective studies have reported seasonal variations in the relapse of ulcerative colitis, and two studies have found seasonality in the onset ofulcerative colitis, with a peak from August to January. This study was designed to investigate possible seasonal variations of onset of ulcerative colitis (UC) and Crohn's disease (CD). Patients with symptoms of one year or less were recruited from a prospective study of the incidence of inflammatory bowel disease, and the onset of symptoms was recorded month by month for four consecutive years. A total of 420 patients with UC and 142 patients with CD were included. There was monthly seasonality (p=0.028) in symptomatic onset in December and January for UC but not for CD. It was found that environmental agents with known seasonality can be of importance for the seasonal variations of disease onset inUC.
analysing seasonal variations in the onset of disease.' 24 All the studies have used retrospectively assembled data or hospital admission, however, which may have lead to a bias in the results. In three retrospective studiesl 2 4 dealing with the symptomatic onset of ulcerative colitis (UC), seasonal variation in the onset was reported in two with a peak in December4 and from August to January.2 In the third study,1 no seasonality was found.
This study was designed to investigate whether there were seasonal variations in the onset of symptoms in patients with UC and Crohn's disease (CD). The patients were recruited from an ongoing study of incidence and the onset of symptoms was recorded for each month over four consecutive years of registration.
Methods
In a prospective incidence study of IBD in south eastern Norway, the onset of disease specific symptoms was registered in a standardised manner.13 The 
1 3 5 7 9 11 1 3 5 7 9 11 1 3 5 7 9 11 1 3 5 7 9 11 2 4 6 8 10 12 2 4 6 8 10 12 2 4 6 8 10 12 2 4 6 8 (Table I) , and the determination of disease onset was considered to be reliable. In prospective incidence studies of IBD, the inclusion of an accumulation of previously undiagnosed cases may cause a drop in the length of the disease duration, which may give an impression of seasonality. In this study, the median disease duration remained stable in UC (three months) and CD (four months) throughout the four years of registration, which suggests that the results do not reflect prevalence.
Weight loss initially affected 30%/o of UC and 58% of CD patients (Table I) 16 18 19 In this study seasonal variation in the onset of symptoms was found only in UC. This finding was based on the exceedingly high occurrence of symptoms in December and January, and on the lower frequency than expected in April and May. As upper respiratory tract infections have been associated with relapses in UC and CD,46 16 The hypothesis that enteric infections can precipitate the onset of disease is not supported by these findings, as such infections are most common in Norwegians after holidays abroad during the summer. The fact that negative stool cultures and serological tests were a requirement for inclusion in the study, also means that such an association is unlikely.
In this study the numbers of UC patients each month seem to have been sufficient to obtain valid data. The comparatively smaller number of CD patients for each month, however, must be interpreted with caution, as a seasonality similar to that for UC cannot be ruled out.
In conclusion, the prospective registration of seasonal variations in the symptomatic onset in IBD showed seasonality in UC but not in CD. Factors related to climate may be at least partly responsible for the seasonal variation and the high incidence of UC found in Norway. Accordingly, pathogens with seasonal fluctuations may be of crucial importance for the occurrence of IBD. These findings need to be further investigated. 
